In our study, we found a significant increase in serum levels of MCP-1 in patients with HS compared to controls, confirming what has been reported on other inflammatory skin diseases such as psoriasis and atopic dermatitis, and in sweat samples from HS patients [55,56,57]. Here, CCL2 is linked to histiocytic sarcoma.